Oral esomeprazole in Japanese pediatric patients with gastric acid ‐related diseases: Safety, Efficacy, and Pharmacokinetics
ConclusionsOral esomeprazole, at 10 mg or 20 mg once daily, demonstrated a similar safety, efficacy, and pharmacokinetic profile in Japanese pediatric patients to that previously seen in adults and Caucasian children.This article is protected by copyright. All rights reserved.
Source: Pediatrics International - Category: Pediatrics Authors: Toshiaki Shimizu,
Yoshiko Nakayama,
Eizaburo Ishii,
Shinobu Ida,
Tomoki Satou,
Daisuke Tokuhara,
Katsuhiro Arai,
Masahiro Nii,
Hans Rydholm,
Toshitaka Yajima,
The J ‐NEPECS Group Tags: Original Articles Source Type: research
More News: Children | Esomeprazole | Gastroenterology | Japan Health | Nexium | Pediatrics | Proton Pump Inhibitors PPIs | Study